• SENSEX 77,301.40
    383.55 (+0.50%)
  • BANKNIFTY 55,913.60
    373.55 (+0.67%)
  • NSE
    1,824.90 1,878.00(%)
  • Reliance Industries
    1,318.95 1,611.20(%)
  • Bharti Airtel
    2,068.00 2,174.70(%)
  • SBI Life Insuran
    1,706.80 2,132.90(%)
  • Saregama India
    652.00 652.00(%)
  • Aster DM Quality
    728.05 890.95(%)
  • Multi Comm. Exc.
    3,252.50 1,761.43(%)
  • Jio Platforms
    1,415.00 1,356.40(%)
  • Shree Cement
    24,342.85 28,306.45(%)
  • SFC Enviro.
    397.60 354.05(%)
  • HDFC Bank
    741.00 1,017.90(%)
  • BLS Polymers
    245.95 225.00(%)
  • Global Health
    1,422.10 1,542.00(%)
  • J K Cements
    5,048.20 4,670.05(%)
  • Info Edg.(India)
    1,159.40 909.20(%)
  • ITC
    283.50 414.65(%)
  • SBI
    987.75 1,234.80(%)
  • M & M
    2,952.00 3,840.00(%)
  • Fractal Analyt.
    844.40 1,119.60(%)
  • Ajmera Realty
    145.45 216.02(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Zota Health Care Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 69688.0
  • ISIN : INE358U01012
1,217.90 -14 (-1.16%)
  • As on 05 Nov 2026 (EOD)
  • Today’s Low

    1,207.00
  • Today’s High

    1,241.90
  • Open

    1,239.00
  • Perv Close

    1,232.20
  • 52W Low

    1,022.00
  • 52W High

    1,740.00

Key Indicators

  • P/E(TTM)

    268.26

  • Mar.Cap (₹Cr.)

    4,217.90

  • Div & Yield %

    0.08

  • Book Value(₹)

    257.66

  • Debt-Equity Ratio

    -1.16

  • AGM Date

    04-Nov-2026

  • EPS

    4.54

  • P/E Ratio

    268.26

Financials Ratios

  • Debt-Equity Ratio

    0.82

  • Mar.Cap (₹Cr.)

    4,217.90

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    34.63

  • BV (₹)

    257.70

  • Sales( ₹ in Cr.)

    407.01

  • NP (in Cr.)

    28.60

  • NP Var(%)

    232.0

  • Div%

    10.0

  • CPS (₹)

    9.40

  • EPS (₹)

    8.30

  • Traded Value (₹ in Lakhs)

    4,217.90

  • 52 Week High

    1,740.00

  • 52 Week Low

    1,022.00

  • Price BSE

    0.0

  • Price NSE

    1,218.00

  • Market Capital( in Cr.)

    4,217.90

  • P/C Ratio

    129.60

  • P/E Ratio

    147.50

  • Price Vs.BV

    8.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 407.01 257.28 166.59 138.37 131.53 106.84
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 407.01 257.28 166.59 138.37 131.53 106.84
Other Income 13.40 4.62 2.05 3.10 1.65 2.29
Stock Adjustments 25.51 16.14 3.53 11.00 -1.48 2.14
Total Income 445.92 278.04 172.17 152.47 131.70 111.27
EXPENDITURE :            
Raw Materials 256.74 173.23 108.83 99.41 86.67 75.88
Power and Fuel Cost 1.07 1.13 0.97 0.73 0.84 0.70
Employee Cost 44.61 29.15 18.85 10.73 9.15 8.58
Other Manufacturing Expenses 3.96 3.23 2.00 0.93 1.43 1.55
Selling and Administration Expenses 94.26 54.79 33.11 29.40 16.54 21.43
Miscellaneous Expenses 1.30 0.44 0.12 0.16 0.07 0.16
Employee Benefit Expenses 44.61 29.15 18.85 10.73 9.15 8.58
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 401.95 261.98 163.89 141.35 114.70 108.30
Operating Profit 43.97 16.07 8.27 11.10 16.99 2.96
Interest 0.25 1.06 0.36 0.06 0.07 0.11
Gross Profit 43.72 15.01 7.91 11.04 16.92 2.85
Depreciation 3.95 3.17 3.01 2.42 2.73 3.17
Profit Before Tax 39.77 11.84 4.90 8.62 14.19 -0.32
Current Tax 10.84 3.36 1.47 2.05 3.69 0.02
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.01 -0.13 0.06 -0.02 -0.08 -0.17
Reported Net Profit 27.91 8.62 3.38 6.59 10.58 -0.16
Extraordinary Items -0.69 0.00 0.00 0.40 0.00 0.94
Adjusted Net Profit 28.60 8.62 3.38 6.19 10.58 -1.10
Adjustment below Net Profit -47.71 38.57 5.70 0.27 0.14 0.14
P & L Balance brought forward 74.49 30.05 23.55 20.46 12.26 14.74
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 3.06 2.74 2.58 3.77 2.52 2.46
P & L Balance carried down 51.62 74.49 30.05 23.55 20.46 12.26
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 10.00 10.00 15.00 10.00
Dividend Per Share(Rs) 1.00 1.00 1.00 1.00 1.50 1.00
Earnings Per Share-Unit Curr 8.06 3.01 1.31 2.62 4.21 -0.07
Earnings Per Share(Adj)-Unit Curr 8.06 3.01 1.31 2.62 4.21 -0.07
Book Value 256.46 110.83 47.11 37.54 36.32 27.02
Book Value(Adj)-Unit Curr 256.46 110.83 47.11 37.54 36.32 27.02

Shareholding Pattern

  • Promoter Group

    49.38%

  • Public Share Holding

    50.62%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 17,102,433 49.38 17,102,433 40
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 17,102,433 49.38 17,102,433 40
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 2,395,685 6.92 2,395,685 19
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 126,548 0.37 126,548 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,400,788 6.93 2,400,788 17
Trusts 40 0.00 40 2
Venture Capital Funds 0 0.00 0 0
Sub total 4,923,061 14.22 4,923,061 39
2] Non Institution
Bodies Corporate 598,509 1.73 598,509 126
Clearing Members 570,030 1.65 570,030 15
Directors of their Relatives 169,960 0.49 169,960 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 135,048 0.39 135,048 328
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 640,460 1.85 640,460 672
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,612,007 16.20 5,612,007 51
Individuals holding nominal share capital up to Rs. 1 lakh 4,415,822 12.75 4,394,987 13,608
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 145,521 0.42 145,521 4
Sub Total 12,607,093 36.40 12,586,258 14,849
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 34,632,587 100.00 34,611,752 14,928

Company Background

Zota Health Care LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Zota Health Care Ltd
  • BSE Code : 69688.0
  • ISIN : INE358U01012
  • Incorporation Year

    2000

  • Registered Office

    Zota House 2/896 Hira Modi St
    Sagrampura, Surat,
    Gujarat-395002

  • Telephone

    91-261-2331601

  • FAX

    91-261-2346415

  • Chairman

    Ketankumar Zota

  • Managing Director

    Moxesh Zota

  • Company Secretary

    Ashvin Variya

  • Auditor

    Pradeep K Singhi & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Satellite Corporate Ser. P Ltd
    Unit-49 Bldg-13 AB ,
    Off Andheri Kurla Rd,MTNL Lane Sakinaka
    Mumbai - Mumbai-400072

Zota Health Care Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Zota Health Care 1,217.90 420.41 407.01 279.33 6.50
Abbott India 27,146.85 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,365.10 2,304.07 2,275.58 93.81 27.86
Glaxosmi. Pharma 2,532.60 3,932.76 3,790.20 40.46 58.17
Evonile Pharma 1,736.60 393.10 354.33 43.85 15.94
Cipla 1,400.10 20,102.60 18,979.95 42.67 13.88
Bliss GVS Pharma 625.60 773.53 729.81 40.78 12.51
Amrutanjan Healt 511.45 520.13 502.55 27.39 24.16
Fermenta Biotec. 439.00 474.15 450.25 20.49 18.77
Guj. Themis Bio. 387.70 168.25 165.82 103.66 18.05
Ambalal Sarabhai 35.67 19.52 3.94 66.06 6.77